JP2002512005A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002512005A5 JP2002512005A5 JP2000536866A JP2000536866A JP2002512005A5 JP 2002512005 A5 JP2002512005 A5 JP 2002512005A5 JP 2000536866 A JP2000536866 A JP 2000536866A JP 2000536866 A JP2000536866 A JP 2000536866A JP 2002512005 A5 JP2002512005 A5 JP 2002512005A5
- Authority
- JP
- Japan
- Prior art keywords
- molecule
- amino acid
- cdna
- antibody
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002299 complementary DNA Substances 0.000 description 11
- 239000002773 nucleotide Substances 0.000 description 9
- 125000003729 nucleotide group Chemical group 0.000 description 9
- 125000003275 alpha amino acid group Chemical group 0.000 description 8
- 238000000034 method Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 230000000692 anti-sense effect Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/040,485 US6166176A (en) | 1998-03-17 | 1998-03-17 | Cancer marker protein and peptides thereof |
| US09/040,485 | 1998-03-17 | ||
| PCT/US1999/005365 WO1999047683A1 (en) | 1998-03-17 | 1999-03-11 | Gene encoding labyrinthin, a marker for cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009110164A Division JP2009165492A (ja) | 1998-03-17 | 2009-04-28 | ガンについてのマーカーである、ラビリンチンをコードする遺伝子 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002512005A JP2002512005A (ja) | 2002-04-23 |
| JP2002512005A5 true JP2002512005A5 (enExample) | 2006-04-27 |
Family
ID=21911225
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000536866A Pending JP2002512005A (ja) | 1998-03-17 | 1999-03-11 | ガンについてのマーカーである、ラビリンチンをコードする遺伝子 |
| JP2009110164A Pending JP2009165492A (ja) | 1998-03-17 | 2009-04-28 | ガンについてのマーカーである、ラビリンチンをコードする遺伝子 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009110164A Pending JP2009165492A (ja) | 1998-03-17 | 2009-04-28 | ガンについてのマーカーである、ラビリンチンをコードする遺伝子 |
Country Status (14)
| Country | Link |
|---|---|
| US (7) | US6166176A (enExample) |
| EP (1) | EP1062346B1 (enExample) |
| JP (2) | JP2002512005A (enExample) |
| CN (2) | CN100372938C (enExample) |
| AP (1) | AP2000001917A0 (enExample) |
| AT (1) | ATE337400T1 (enExample) |
| AU (2) | AU762758B2 (enExample) |
| BR (1) | BR9908886A (enExample) |
| CA (1) | CA2323494A1 (enExample) |
| DE (1) | DE69932926T2 (enExample) |
| EA (1) | EA003735B1 (enExample) |
| IL (1) | IL138208A0 (enExample) |
| OA (1) | OA11487A (enExample) |
| WO (1) | WO1999047683A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6166176A (en) * | 1998-03-17 | 2000-12-26 | Immvarx, Inc. | Cancer marker protein and peptides thereof |
| US6835370B2 (en) | 1999-11-08 | 2004-12-28 | Rhode Island Hospital | Diagnosis and treatment of malignant neoplasms |
| US20030031670A1 (en) * | 1999-11-08 | 2003-02-13 | Jack R. Wands | Diagnosis and treatment of malignant neoplasms |
| US20050123545A1 (en) * | 1999-11-08 | 2005-06-09 | Wands Jack R. | Diagnosis and treatment of malignant neoplasms |
| US6682902B2 (en) * | 1999-12-16 | 2004-01-27 | Schering Aktiengesellschaft | DNA encoding a novel RG1 polypeptide |
| US7306919B1 (en) | 2001-10-31 | 2007-12-11 | Thornthwaite Jerry T | Antigen-antibody cancer recognition system |
| EP1536814A4 (en) * | 2002-07-03 | 2006-02-15 | Immunogen Inc | ANTIBODIES AGAINST MUC1 AND MUC16 NOT RELEASED AND USES THEREOF |
| DE60324794D1 (de) * | 2003-09-04 | 2009-01-02 | Biomay Ag | Hypoallergene Polypeptide basierend auf aus Fisch gewonnenem Parvalbumin |
| EP1699485A4 (en) * | 2003-11-14 | 2007-12-19 | Massachusetts Inst Technology | ANTI-HYDROLYSATE ANTIBODIES AND ITS USES |
| CN100457922C (zh) * | 2005-10-20 | 2009-02-04 | 康哲医药研究(深圳)有限公司 | 检测酪丝亮肽抗肝癌效果的方法及所用试剂盒与基因芯片 |
| RU2340896C1 (ru) * | 2007-05-17 | 2008-12-10 | Негосударственное научно-исследовательское учреждение "Биомедицинский центр" | Способ диагностики онкологических заболеваний |
| GB201002627D0 (en) | 2010-02-16 | 2010-03-31 | Loxbridge Res Llp | Aptamer based analyte detection method |
| TW202039536A (zh) * | 2018-12-13 | 2020-11-01 | 美商拉比林免疫治療美國有限公司 | 用於癌症免疫療法之基於拉比林(labyrinthin)之肽及其用途 |
| JP2022517329A (ja) * | 2019-01-08 | 2022-03-08 | ラビアールエックス イミュノロジック セラピューティクス （ユーエスエー） リミテッド | ラビリンチン又はその一部を標的とする構築物及びその使用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816402A (en) * | 1986-01-07 | 1989-03-28 | Northwestern University | Murine hybridoma and diagnostic antibody produced thereby |
| WO1994004679A1 (en) * | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
| US5223604A (en) * | 1991-06-25 | 1993-06-29 | S.P.I. Synthetic Peptides Incorporated | Pseudomonas exoenzyme s peptide composition and method |
| US5728819A (en) * | 1996-08-02 | 1998-03-17 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
| US5994062A (en) | 1995-10-02 | 1999-11-30 | The United States Of America As Represented By The Department Of Health And Human Services | Epithelial protein and DNA thereof for use in early cancer detection |
| US6166176A (en) * | 1998-03-17 | 2000-12-26 | Immvarx, Inc. | Cancer marker protein and peptides thereof |
| US6344548B1 (en) * | 1998-06-24 | 2002-02-05 | The Regents Of The University Of California | Diacylglycerol o-acyltransferase |
| US7135617B2 (en) * | 1998-07-02 | 2006-11-14 | Calgene Llc | Diacylglycerol acyl transferase proteins |
| US6100077A (en) * | 1998-10-01 | 2000-08-08 | The Trustees Of Columbia University In The City Of New York | Isolation of a gene encoding diacylglycerol acyltransferase |
| US20030161831A1 (en) * | 2001-02-23 | 2003-08-28 | Sylvaine Cases | Mono-and diacylglycerol acyltransferases and methods of use thereof |
| US7045326B2 (en) * | 2001-02-23 | 2006-05-16 | The Regents Of The University Of California | Mono- and diacylglycerol acyltransferases and methods of use thereof |
| CA2492205A1 (en) * | 2002-07-31 | 2004-02-05 | Monsanto Technology, Llc | Diacylglycerol acyltransferase nucleic acid sequences and associated products |
| US8685679B2 (en) * | 2004-11-04 | 2014-04-01 | E I Du Pont De Nemours And Company | Acyltransferase regulation to increase the percent of polyunsaturated fatty acids in total lipids and oils of oleaginous organisms |
| US8507754B2 (en) * | 2009-01-31 | 2013-08-13 | University Of North Texas | Engineering lipids in vegetative tissues of plants |
| CA2804025C (en) * | 2010-06-28 | 2023-02-21 | Commonwealth Scientific And Industrial Research Organisation | Methods of producing lipids |
-
1998
- 1998-03-17 US US09/040,485 patent/US6166176A/en not_active Expired - Fee Related
-
1999
- 1999-03-11 CN CNB998061697A patent/CN100372938C/zh not_active Expired - Fee Related
- 1999-03-11 IL IL13820899A patent/IL138208A0/xx unknown
- 1999-03-11 WO PCT/US1999/005365 patent/WO1999047683A1/en not_active Ceased
- 1999-03-11 EP EP99911331A patent/EP1062346B1/en not_active Expired - Lifetime
- 1999-03-11 CA CA002323494A patent/CA2323494A1/en not_active Abandoned
- 1999-03-11 CN CNA2008100031485A patent/CN101260401A/zh active Pending
- 1999-03-11 AT AT99911331T patent/ATE337400T1/de not_active IP Right Cessation
- 1999-03-11 BR BR9908886-0A patent/BR9908886A/pt not_active Application Discontinuation
- 1999-03-11 JP JP2000536866A patent/JP2002512005A/ja active Pending
- 1999-03-11 EA EA200000845A patent/EA003735B1/ru not_active IP Right Cessation
- 1999-03-11 DE DE69932926T patent/DE69932926T2/de not_active Expired - Lifetime
- 1999-03-11 AU AU29996/99A patent/AU762758B2/en not_active Ceased
- 1999-03-11 AP APAP/P/2000/001917A patent/AP2000001917A0/en unknown
-
2000
- 2000-09-12 US US09/659,521 patent/US6727080B1/en not_active Expired - Fee Related
- 2000-09-18 OA OA1200000256A patent/OA11487A/en unknown
-
2003
- 2003-05-22 AU AU2003204331A patent/AU2003204331B2/en not_active Ceased
-
2004
- 2004-04-23 US US10/830,702 patent/US7329743B2/en not_active Expired - Fee Related
-
2008
- 2008-02-11 US US12/029,113 patent/US7635759B2/en not_active Expired - Fee Related
-
2009
- 2009-04-28 JP JP2009110164A patent/JP2009165492A/ja active Pending
- 2009-10-23 US US12/605,185 patent/US8163883B2/en not_active Expired - Fee Related
-
2010
- 2010-03-16 US US12/725,414 patent/US20100233711A1/en not_active Abandoned
- 2010-03-16 US US12/725,404 patent/US20110110963A1/en not_active Abandoned